Assessing platelet function during treatment with glycoprotein IIb/IIIa antagonists.
Steinhubl
Steven R
SR
Department of Medicine, University of North Carolina, Chapel Hill, 27599-7075, USA. steinhub@med.unc.edu
D000085:Acetates / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology*; D000077542:Eptifibatide; D006801:Humans; D010455:Peptides / Q000627:therapeutic use; D015539:Platelet Activation / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D014443:Tyrosine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use
D000085:Acetates; D010455:Peptides; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D014443:Tyrosine; C084062:lamifiban; D000077542:Eptifibatide